NAPWA Treatments Campaign 2012Start the Treatments ConversationPhillip Keenphillip@napwa.org.auMay 2012
Overview• Background & rationale• Campaign goals and objectives• Campaign materials & Implementation• Evaluation and next ...
HIV Treatments: science and expert opinion• Untreated HIV infection may have detrimental effects at all stages of infect...
Minimum, Most Recent, Maximum CVL and Newly Diagnosed and Reported HIV cases
ARV Treatment Guidelines• March 2012 Update to US DHHS Guidelines (followed in Australia):• ART is recommended for all HI...
But outdated beliefs• Indications that knowledge among some PLHIV about treatment advances is not consistently reviewed o...
Psychological barriers“Commencing was terrifying. I was scared and the night before I started I was a mess. Initial phys...
What Proportion of the PLHIV Population is on Treatments? Source Proportion on ARVsHighly S...
Treatments Uptake Needed• NAPWA Treatments Target: 90% on treatments by 2015• Rapid increases in treatments uptake occurre...
Median CD4 at Diagnosis 2007 2008 2009 2010Australia 424 420 40...
CD4 at start of cART (closest CD4 with 6 monthsprior) Prior to 1 Jan 1 Jan 2006 ...
Psychological barriers“The barrier to commence my HIV treatment was the hardest thing to work through personally. It too...
Campaign: Goals and Objectives• Health Issue: o Some people living with HIV who would benefit from HIV treatments ar...
Launch
Posters and Print advertisements Version 1 Long copy I...
Posters and Print advertisementsVersion 2 ImageSydney Morning Herald(Spectrum)Saturday AgeCourier Mail SaturdayStar O...
Billboards, Bus & tramsides.Sydney, Melbourne,BrisbaneShort copyIf you’re living with HIV,Start a treatmentconversationWit...
Billboards
Website Content• Benefits of early initiation of HIV treatments- for PLHIV and in protecting partners• HIV treatment guid...
Evaluation and next steps• Generation II of campaign o Online advertising• External evaluation• Next Campaign: o PLHIV...
Barriers to Treatments Uptake• Reducing barriers to treatment o Dispensing arrangements o Co-payments • Difficult...
Thanks
NAPWA Treatments Campaign 2012: Start the Treatments Conversation
of 23

NAPWA Treatments Campaign 2012: Start the Treatments Conversation

Phillip Keen, (NAPWA) discusses the background, goals and objectives of NAPWA's billboard and web campaign encouraging people with HIV to get up to date about treatments. This presentation was given at the AFAO/NAPWA Gay Men's HIV Health Promotion Conference in May 2012.
Published on: Mar 3, 2016
Published in: Health & Medicine      
Source: www.slideshare.net


Transcripts - NAPWA Treatments Campaign 2012: Start the Treatments Conversation

  • 1. NAPWA Treatments Campaign 2012Start the Treatments ConversationPhillip Keenphillip@napwa.org.auMay 2012
  • 2. Overview• Background & rationale• Campaign goals and objectives• Campaign materials & Implementation• Evaluation and next steps
  • 3. HIV Treatments: science and expert opinion• Untreated HIV infection may have detrimental effects at all stages of infection. Later treatment may not repair damage associated with viral replication and immune activation during early stages of infection.• Earlier treatment may prevent the damage associated with HIV replication during early stages of infection.• Earlier treatment may reduce risk cardiovascular disease, cancers, osteopenia/osteoporosis and neurologic complications.• Prevention benefits of HIV treatments (HPTN 052/Test & Treat)
  • 4. Minimum, Most Recent, Maximum CVL and Newly Diagnosed and Reported HIV cases
  • 5. ARV Treatment Guidelines• March 2012 Update to US DHHS Guidelines (followed in Australia):• ART is recommended for all HIV-infected individuals. The strength of this recommendation varies on the basis of pre-treatment CD4 cell count: o CD4 count <350 cells/mm3 (AI) o CD4 count 350 to 500 cells/mm3 (AII) o CD4 count >500 cells/mm3 (BIII)
  • 6. But outdated beliefs• Indications that knowledge among some PLHIV about treatment advances is not consistently reviewed or renewed• Past negative experiences in terms of pill burden, side effects and toxicities influencing attitudes and beliefs• S100 prescribers play a very important role in guiding decisions about initiating treatment• Optimal health outcomes for PLHIV will be supported by addressing psychosocial and structural barriers
  • 7. Psychological barriers“Commencing was terrifying. I was scared and the night before I started I was a mess. Initial physical reaction was minimal so that was a relief. Changing meds is also a scary thought which I am trying to avoid” (ARCSHS Tracking Changes, 2011)“I had thought it would be difficult for me to commence meds since this would be an acknowledgment of the progression of my HIV. However since starting my meds I have found that a lot of small irritating conditions have cleared up and my overall health is significantly improved. Im just grateful every day that the meds exist!” (ARCSHS Tracking Changes, 2011)
  • 8. What Proportion of the PLHIV Population is on Treatments? Source Proportion on ARVsHighly Specialised Drugs Program 53.9%(January – June 2010) / Kirby ASR (2009: 52.5%) Gay Community Periodic Surveys (2010 Data , ARTB 2011) 69.5% Futures 6 (2009) 79.6% AHOD (2010) 89%
  • 9. Treatments Uptake Needed• NAPWA Treatments Target: 90% on treatments by 2015• Rapid increases in treatments uptake occurred previously: 1996-1998 (20% > 70%) Year Estimated Proportion Population Additional Population on ARVs not on ARVs needed if 90% 2010 21,391 70% 6,417 4,278 2011 22,391 70% 6,717 4,478
  • 10. Median CD4 at Diagnosis 2007 2008 2009 2010Australia 424 420 406 399NSW (M) 443 440 408 410NSW (W) 300 450 380 356 Source ASR/State & Territory health authorities
  • 11. CD4 at start of cART (closest CD4 with 6 monthsprior) Prior to 1 Jan 1 Jan 2006 2006 onwards Overall Total 1882 427 2309 Mean 327.9 324.0 327.1 SD 242.4 193.5 234.1 Median 288.5 294 290 25th 150 200 160 75th 450 422 445 n (%) n (%) n (%) 250-349 347 (18.4) 101 (23.6) 448 (19.4) <250 787 (41.8) 161 (37.7) 948 (41.1) >=350 748 (39.7) 165 (38.6) 913 (39.5)
  • 12. Psychological barriers“The barrier to commence my HIV treatment was the hardest thing to work through personally. It took my doctor three years to convince me it was the right thing to do. In hindsight having now been on meds for over a year and my health at its best I wish I could have known and started them earlier. It’s important for others facing this hurdle to speak with people that have faced this....with positive outcomes.” (ARCSHS Tracking Changes, 2011)
  • 13. Campaign: Goals and Objectives• Health Issue: o Some people living with HIV who would benefit from HIV treatments are not accessing them due to outdated understandings about their benefits and risks.• Campaign Goal: o To mobilise people living with HIV to achieve better health outcomes through increased access to appropriate HIV treatments.• Campaign Objectives: o To encourage people living with HIV to become better informed about the benefits of HIV treatments for themselves and their partners. o To encourage people living with HIV to talk to their doctor about the latest information about HIV treatments and whether initiating HIV treatments would benefit them.
  • 14. Launch
  • 15. Posters and Print advertisements Version 1 Long copy If you’re living with HIV then talk to your doctor. Early treatment can have important health benefitsAnd can protect your partners. Don’t put off treatment Any longer and learn about the latest developments. START THE CONVERSATION TODAY
  • 16. Posters and Print advertisementsVersion 2 ImageSydney Morning Herald(Spectrum)Saturday AgeCourier Mail SaturdayStar ObserverSXQueensland PrideMen’s Health
  • 17. Billboards, Bus & tramsides.Sydney, Melbourne,BrisbaneShort copyIf you’re living with HIV,Start a treatmentconversationWith your doctor
  • 18. Billboards
  • 19. Website Content• Benefits of early initiation of HIV treatments- for PLHIV and in protecting partners• HIV treatment guidelines• Psychological barriers to initiating and switching HIV treatments• Working with your doctor & where to find S100 docs
  • 20. Evaluation and next steps• Generation II of campaign o Online advertising• External evaluation• Next Campaign: o PLHIV peer experiences of treatments• Policy work
  • 21. Barriers to Treatments Uptake• Reducing barriers to treatment o Dispensing arrangements o Co-payments • Difficulties obtaining medication and co-payments associated with stopping ARVs (ARCSHS Tracking Changes, 2011)• ATRAS and other Medicare Ineligibles• Addressing Psychological barriers to initiating treatment o Recommend doctors commence discussing treatments at or soon after diagnosis & assess psychological supports needed
  • 22. Thanks

Related Documents